Revolka

  • about us
  • business
  • case studies
  • pipeline
  • investors
  • news
  • contact
  • jp
  • en
    • about us
    • investors
    • faq
    • contact
    • business
    • aiProtein®
    • RevoAb™
    • results
    • pipeline
    • news

contact Let's explore new
possibilities together.

  1. top
  2. News
  3. RevolKa has been selected as a member of the Google for Startups Cloud Program.

2022.11.14

  • news

RevolKa has been selected as a member of the Google for Startups Cloud Program.

Our company has been adopted for the “Google for Startups cloud program” provided by Google.

https://inthecloud.withgoogle.com/startup-ja/dl-cd.html

  • Previous Article
  • Next Article
  • Back to List

Related Articles

  • 2025.09.09

    • news

    ‘RevoAb™’: A New Service for Antibody Developability Engineering

  • 2025.06.30

    • news

    RevolKa Ltd. Joins Research and Development Program for Innovative Biologics Funded by the Japanese Agency for Medical Research and Development (AMED)

  • 2025.05.20

    • news

    RevolKa Ltd. Secures 210 million JPY (US$1.4 million) Series A Extension Funding to Advance Therapeutic Programs

News List

contact Let's explore new
possibilities together.
From solving protein design challenges to joint research,
RevolKa's aiProtein® technology accelerates your business.
Feel free to contact us for a consultation.
Our expert team will propose the optimal solution.
  • Corporate Information

    • about us
    • investors
    • faq
    • contact
  • Business &
    Technology

    • business
    • aiProtein®
    • RevoAb™
  • Information &
    Case Studies

    • case studies
    • pipeline
    • news
Revolka

ページトップへ

  • privacy policy
  • legal notice
  • Cookie Settings

© 2025 RevolKa Ltd. All Rights Reserved.